Cleveland-based CHAMPS Group Purchasing, a national group purchasing organization (GPO) with more than 25,000 member locations…
Category: Insights
Healthcare Services Market to Grow by USD 6.26 Trillion (2024-2028), Driven by Rising Chronic Disease Prevalence, Report Highlights AI-Powered Market Evolution
Report on how AI is driving market transformation – The global healthcare services market size is estimated to…
MedStar Health First in Maryland to Implant FDA Approved Tricuspid Valves in Patients Without Need for Open Heart Surgery
In two separate procedures, MedStar Health cardiac experts at MedStar Union Memorial Hospital reached new heights…
Springbok Analytics Announces $5M Series A to Advance Its Leadership in Muscle Health Analysis
Springbok Analytics (www.springbokanalytics.com), a leader in AI-driven muscle analytics, today announced the close of an oversubscribed $5M Series A…
THE AMERICAN KENNEL CLUB WELCOMES THE DANISH-SWEDISH FARMDOG TO THE PACK
The American Kennel Club (AKC®), the world’s largest purebred dog registry and leading advocate for dogs,…
PieX AI: Launching the World’s First Personalized, On-device AI Pendant at CES 2025
PieX AI, a global leader in multimodal AI hardware for smart health, is set to proudly…
Psychedelic Drug Therapy May Address Mental Health Concerns in People with Cancer and Addiction
One or two doses of psilocybin, a compound found in psychedelic mushrooms, may improve the mental health…
Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Atopic Dermatitis and Asthma Therapies Antibody Drug MG-K10 Late-Stage Clinical Trials and Commercialization
Chime Biologics, a leading global CDMO that enables its partners’ success in biologics, and Mabgeek, a clinical-stage…
iXpressGenes Appoints John Schmitt as CEO, Announces Nationwide TAI Test Launch
iXpressGenes (iXG), a biotechnology company transforming trauma care, is proud to appoint co-founder John Schmitt as Chief Executive…
Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies…